Epigenetic and transcriptional control of interferon-β

J Exp Med. 2021 Sep 6;218(9):e20210039. doi: 10.1084/jem.20210039. Epub 2021 Jul 23.

Abstract

The three classes of interferons (IFNs) share the ability to inhibit viral replication, activating cell transcriptional programs that regulate both innate and adaptive responses to viral and intracellular bacterial challenge. Due to their unique potency in regulating viral replication, and their association with numerous autoimmune diseases, the tightly orchestrated transcriptional regulation of IFNs has long been a subject of intense investigation. The protective role of early robust IFN responses in the context of infection with SARS-CoV-2 has further underscored the relevance of these pathways. In this viewpoint, rather than focusing on the downstream effects of IFN signaling (which have been extensively reviewed elsewhere), we will summarize the historical and current understanding of the stepwise assembly and function of factors that regulate IFNβ enhancer activity (the "enhanceosome") and highlight opportunities for deeper understanding of the transcriptional control of the ifnb gene.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • CCAAT-Enhancer-Binding Proteins / genetics
  • CCAAT-Enhancer-Binding Proteins / metabolism
  • DNA Methylation
  • Enhancer Elements, Genetic
  • Epigenesis, Genetic*
  • Gene Expression Regulation*
  • Host-Pathogen Interactions / genetics
  • Host-Pathogen Interactions / physiology*
  • Humans
  • Influenza A Virus, H5N1 Subtype / pathogenicity
  • Interferon-beta / genetics*
  • Interferon-beta / metabolism
  • Promoter Regions, Genetic
  • SARS-CoV-2 / pathogenicity
  • Transcription, Genetic
  • Ubiquitin-Protein Ligases / genetics
  • Ubiquitin-Protein Ligases / metabolism

Substances

  • CCAAT-Enhancer-Binding Proteins
  • Interferon-beta
  • UHRF1 protein, human
  • Ubiquitin-Protein Ligases